942 related articles for article (PubMed ID: 24486120)
21. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
Lu Q; Long H; Chow S; Hidayat S; Danarti R; Listiawan Y; Deng D; Guo Q; Fang H; Tao J; Zhao M; Xiang L; Che N; Li F; Zhao H; Lau CS; Ip FC; Ho KM; Paliza AC; Vicheth C; Godse K; Cho S; Seow CS; Miyachi Y; Khang TH; Ungpakorn R; Galadari H; Shah R; Yang K; Zhou Y; Selmi C; Sawalha AH; Zhang X; Chen Y; Lin CS
J Autoimmun; 2021 Sep; 123():102707. PubMed ID: 34364171
[TBL] [Abstract][Full Text] [Related]
22. Dermatologic Manifestations, Histologic Features and Disease Progression among Cutaneous Lupus Erythematosus Subtypes: A Prospective Observational Study in Asians.
Chanprapaph K; Tankunakorn J; Suchonwanit P; Rutnin S
Dermatol Ther (Heidelb); 2021 Feb; 11(1):131-147. PubMed ID: 33280074
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous lupus erythematosus: An update.
Grönhagen CM; Nyberg F
Indian Dermatol Online J; 2014 Jan; 5(1):7-13. PubMed ID: 24616847
[TBL] [Abstract][Full Text] [Related]
24. Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus.
Kuhn A; Ruland V; Bonsmann G
Lupus; 2010 Aug; 19(9):1036-46. PubMed ID: 20693197
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous lupus erythematosus: diagnosis and treatment.
Okon LG; Werth VP
Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):391-404. PubMed ID: 24238695
[TBL] [Abstract][Full Text] [Related]
26. Ten-year retrospective clinicohistological study of cutaneous lupus erythematosus in Korea.
Oh EH; Kim EJ; Ro YS; Ko JY
J Dermatol; 2018 Apr; 45(4):436-443. PubMed ID: 29423919
[TBL] [Abstract][Full Text] [Related]
27. An Update on the Pathogenesis of Skin Damage in Lupus.
Li Q; Wu H; Zhou S; Zhao M; Lu Q
Curr Rheumatol Rep; 2020 May; 22(5):16. PubMed ID: 32399815
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of cutaneous lupus erythematosus.
Szczęch J; Rutka M; Samotij D; Zalewska A; Reich A
Postepy Dermatol Alergol; 2016 Feb; 33(1):13-7. PubMed ID: 26985173
[TBL] [Abstract][Full Text] [Related]
29. [Cutaneous lupus erythematosus. Part 2: diagnostics and therapy].
Kuhn A; Gensch K; Ständer S; Bonsmann G
Hautarzt; 2006 Apr; 57(4):345-8; quiz 359. PubMed ID: 16547761
[TBL] [Abstract][Full Text] [Related]
30. The use of antibody to C5b-9 in the subclassification of lupus erythematosus.
Magro CM; Crowson AN; Harrist TJ
Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325
[TBL] [Abstract][Full Text] [Related]
31. Skin CD4
Zhao Z; Zhu H; Li Q; Liao W; Chen K; Yang M; Long D; He Z; Zhao M; Wu H; Lu Q
J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775
[TBL] [Abstract][Full Text] [Related]
32. Clinical manifestations of cutaneous lupus erythematosus.
Werth VP
Autoimmun Rev; 2005 Jun; 4(5):296-302. PubMed ID: 15990077
[TBL] [Abstract][Full Text] [Related]
33. FOXP3+ and CD39+ regulatory T cells in subtypes of cutaneous lupus erythematosus.
Gambichler T; Pätzholz J; Schmitz L; Lahner N; Kreuter A
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1972-7. PubMed ID: 25808110
[TBL] [Abstract][Full Text] [Related]
34. Distinguishing subacute cutaneous from other types of lupus erythematosus.
McCauliffe DP
Lancet; 1998 May; 351(9115):1527-8. PubMed ID: 10326532
[No Abstract] [Full Text] [Related]
35. Cutaneous lupus erythematosus: clinico-pathologic correlation.
Filotico R; Mastrandrea V
G Ital Dermatol Venereol; 2018 Apr; 153(2):216-229. PubMed ID: 29368845
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic approach and treatment of cutaneous lupus erythematosus.
Sticherling M; Bonsmann G; Kuhn A
J Dtsch Dermatol Ges; 2008 Jan; 6(1):48-59. PubMed ID: 18190433
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
Li Q; Wu H; Liao W; Zhao M; Chan V; Li L; Zheng M; Chen G; Zhang J; Lau CS; Lu Q
J Autoimmun; 2018 Sep; 93():1-15. PubMed ID: 30017673
[TBL] [Abstract][Full Text] [Related]
38. Epidemiological characteristics of patients with cutaneous lupus erythematosus.
Avilés Izquierdo JA; Cano Martínez N; Lázaro Ochaita P
Actas Dermosifiliogr; 2014; 105(1):69-73. PubMed ID: 24268922
[TBL] [Abstract][Full Text] [Related]
39. Clinical course and prognosis of cutaneous lupus erythematosus.
Tebbe B
Clin Dermatol; 2004; 22(2):121-4. PubMed ID: 15234012
[TBL] [Abstract][Full Text] [Related]
40. B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.
Abernathy-Close L; Lazar S; Stannard J; Tsoi LC; Eddy S; Rizvi SM; Yee CM; Myers EM; Namas R; Lowe L; Reed TJ; Wen F; Gudjonsson JE; Kahlenberg JM; Berthier CC
Front Immunol; 2021; 12():775353. PubMed ID: 34868043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
